INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 October 2015
|
Net Assets |
£222m |
|
Net Assets per share |
558p |
|
Share price |
509p |
|
Total value of unquoted investments |
£20m |
|
Total number of portfolio companies |
96 |
Top Ten Holdings
|
Company Name |
% NAV |
|
Amgen |
8.0 |
|
Celgene |
8.0 |
|
Gilead |
7.8 |
|
Regeneron |
7.8 |
|
Ophthotech |
4.9 |
|
Biogen |
4.7 |
|
Vertex |
4.1 |
|
Alexion |
4.0 |
|
Incyte |
3.1 |
|
Biomarin |
2.9 |
|
|
----------- |
|
Total |
55.3 |
|
Portfolio Profitability |
% NAV |
|
Profitable |
53 |
|
Turning Profitable 2015 |
7 |
|
Unprofitable |
40 |
|
|
----------- |
|
Total |
100 |
|
Geographical Allocation |
% NAV |
|
US & Canada |
85 |
|
Europe & UK |
15 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted Allocation |
% NAV |
|
Quoted |
91 |
|
Unquoted |
9 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
24 NOVEMBER 2015